Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-105189
Filing Date
2012-03-09
Accepted
2012-03-09 06:07:02
Documents
17
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d286915d10k.htm 10-K 1839014
2 EX-4.7 d286915dex47.htm EX-4.7 56668
3 EX-4.8 d286915dex48.htm EX-4.8 57491
4 EX-10.35 d286915dex1035.htm EX-10.35 31491
5 EX-23.1 d286915dex231.htm EX-23.1 1425
6 EX-31.1 d286915dex311.htm EX-31.1 10785
7 EX-31.2 d286915dex312.htm EX-31.2 10781
8 EX-32.1 d286915dex321.htm EX-32.1 4846
9 EX-32.2 d286915dex322.htm EX-32.2 4862
16 GRAPHIC g286915g81h24.jpg GRAPHIC 53120
17 GRAPHIC g286915g91r33.jpg GRAPHIC 4693
  Complete submission text file 0001193125-12-105189.txt   4346528

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT somx-20111231.xml EX-101.INS 443610
11 XBRL TAXONOMY EXTENSION SCHEMA somx-20111231.xsd EX-101.SCH 12333
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE somx-20111231_cal.xml EX-101.CAL 34021
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE somx-20111231_def.xml EX-101.DEF 13280
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE somx-20111231_lab.xml EX-101.LAB 133926
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE somx-20111231_pre.xml EX-101.PRE 84057
Mailing Address 10935 VISTA SORRENTO PARKWAY SUITE 250 SAN DIEGO CA 92130
Business Address 10935 VISTA SORRENTO PARKWAY SUITE 250 SAN DIEGO CA 92130 (858) 876-6500
Somaxon Pharmaceuticals, Inc. (Filer) CIK: 0001339455 (see all company filings)

EIN.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51665 | Film No.: 12678891
SIC: 2834 Pharmaceutical Preparations